An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Zhejiang University
Jonsson Comprehensive Cancer Center
Mayo Clinic
Beijing Kejing Biotechnology Co., Ltd.
Mainline Biosciences, Inc.
Shanghai Yunying Medical Technology
Shanghai Fengxian District Central Hospital
Case Comprehensive Cancer Center